Clinical Trial Update: A Study to Evaluate the Effect of BioK+ 50B® on Glycemic Control in a Type 2 Diabetes Population [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating BioK+ 50B for glycemic control in adults with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BioK+ 50B

Snippet

Sponsor: Bio-K Plus International Inc. | Conditions: Type2 Diabetes | Phase 2 | Status: UNKNOWN